Attitudes of patients with metastatic breast cancer toward research biopsies

Annals of Oncology

Volumn 24, Issue 7, 2013, Pages 1853-1859

  Seah, D S ^a   Scott, S M ^b   Najita, J ^a   Openshaw, T ^c   Krag, K ^d   Frank, E ^a   Sohl, J ^a   Stadler, Z K ^e   Garrett, M ^c   Silverman, S G ^f   Peppercorn, J ^g   Winer, E P ^a   Come, S E ^b   Lin, Nancy U ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c Cancer Care of Maine ^*  (United States)

^d North Short Cancer Center   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Metastatic breast cancer; Patient's preferences; Research biopsies

Indexed keywords

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; BONE BIOPSY; BONE MARROW BIOPSY; BREAST BIOPSY; BREAST METASTASIS; CANCER PATIENT; CANCER RESEARCH; COMMUNITY HOSPITAL; FEMALE; HEALTH SURVEY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LUNG BIOPSY; MAJOR CLINICAL STUDY; PATIENT ATTITUDE; PRIORITY JOURNAL; RESEARCH SUBJECT; RISK FACTOR; SKIN BIOPSY; TUMOR BIOPSY; UNIVERSITY HOSPITAL;

METASTATIC BREAST CANCER; PATIENT'S PREFERENCES; RESEARCH BIOPSIES;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; PATIENT PARTICIPATION; QUESTIONNAIRES;

EID: 84879799045     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdt067     Document Type: Article

References (22)

1. Peppercorn J, Shapira I, Collyar D et al. Ethics of mandatory research biopsy for correlative end points within clinical trials in oncology. J Clin Oncol 2010; 28: 2635-2640.
2. El-Osta H, Hong D, Wheler J et al. Outcomes of research biopsies in phase I clinical trials: the MD Anderson cancer center experience. Oncologist 2011; 16: 1292-1298.
3. Carey L, Mayer IA. (personal communication).
4. Pentz RD, Xu Z, Lonial S et al. Research participants' views of nontherapeutic biopsies. J Clin Oncol 2008; 26: Abstract 13529.
5. Agulnik M, Oza AM, Pond GR et al. Impact and perceptions of mandatory tumor biopsies for correlative studies in clinical trials of novel anticancer agents. J Clin Oncol 2006; 24: 4801-4807.
6. Simon MS, Du W, Flaherty L et al. Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center. J Clin Oncol 2004; 22: 2046-2052.
7. Mills EJ, Seely D, Rachlis B et al. Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors. Lancet Oncol 2006; 7: 141-148.
8. Avis NE, Smith KW, Link CL et al. Factors associated with participation in breast cancer treatment clinical trials. J Clin Oncol 2006; 24: 1860-1867.
9. Sateren WB, Trimble EL, Abrams J et al. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol 2002; 20: 2109-2117.
10. Kaphingst KA, Janoff JM, Harris LN et al. Views of female breast cancer patients who donated biologic samples regarding storage and use of samples for genetic research. Clin Genet 2006; 69: 393-398.
11. Dowlati A, Haaga J, Remick SC et al. Sequential tumor biopsies in early phase clinical trials of anticancer agents for pharmacodynamic evaluation. Clin Cancer Res 2001; 7: 2971-2976.
12. Pentz RD, White M, Harvey RD et al. Therapeutic misconception, misestimation, and optimism in participants enrolled in phase 1 trials. Cancer 2012; 118: 4571-4578.
13. Ellis PM, Butow PN, Tattersall MH et al. Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate. J Clin Oncol 2001; 19: 3554-3561.
14. Greenland S. Model-based estimation of relative risks and other epidemiologic measures in studies of common outcomes and in case-control studies. Am J Epidemiol 2004; 160: 301-305.
15. Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol 2005; 162: 199-200.
16. Brown AP, Wendler DS, Camphausen KA et al. Performing nondiagnostic research biopsies in irradiated tissue: a review of scientific, clinical, and ethical considerations. J Clin Oncol 2008; 26: 3987-3994.
17. Pentz RD, Harvey RD, White M et al. Research biopsies in phase I studies: views and perspectives of participants and investigators. IRB 2012; 34: 1-8.
18. Olson EM, Lin NU, Krop IE et al. The ethical use of mandatory research biopsies. Nat Rev Clin Oncol 2011; 8: 620-625.
19. Peppercorn J, Shapira I, Deshields T et al. Ethical aspects of participation in the database of genotypes and phenotypes of the National Center for Biotechnology Information: the cancer and leukemia group B experience. Cancer 2012; 118: 5060-5068.
20. Cardoso F, Fallowfield L, Costa A et al. Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2011; 22(Suppl 6): vi25-vi30.
21. Ellis PM. Attitudes towards and participation in randomised clinical trials in oncology: a review of the literature. Ann Oncol 2000; 11: 939-945.
22. Clinical Trials: The Basic Workbook, 2002. http://www.cancer.gov/clinicaltrials/learningabout/basicworkbook (10 November 12, date last accessed).